Medici Brands Raises Significant Series B Funding
Medici Brands, a company known for creating and growing iconic brands across food, tech, and the arts, has successfully raised $250 million in a Series B funding round. This round was co-led by Greenoaks and Valor Equity Partners, with additional participation from notable investors such as Peter Rahal, ICONIQ, and Imaginary Ventures.
Investment Details
The latest investment round was officially announced on September 1, 2026, and is set to accelerate Medici Brands' growth initiatives. The company, headquartered in New York, is the parent of brands like David Protein and the newly launched confectionery brand HallPass.
Leadership and Vision
Peter Rahal, the CEO of Medici Brands, has been instrumental in steering the company's vision of defining new categories in various industries. Under his leadership, the company continues to attract substantial investment to fuel its expansion plans.
Use of Funds
While specific plans for the new funds were not detailed, the capital injection is expected to support Medici Brands' ongoing efforts to innovate and expand its brand portfolio across its focus sectors.
Conclusion
This significant investment marks a pivotal moment for Medici Brands as it continues to build and expand its influence in the food, tech, and arts sectors. With the backing of prominent investors, the company is well-positioned to continue its growth trajectory.